Sana Biotechnology, Inc. (SANA) Misses Q2 EPS by 3c

Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q2 EPS of ($0.45), $0.03 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Jefferies: 38% of Australian companies beat estimates this season
• Walmart (WMT) PT Lowered to $130 at Guggenheim